Case Study: MyMeds&Me improves adverse event reporting with OpenDialog

Collecting Complex Medical Info Consistently And Reliably

MyMeds&Me, a company specializing in adverse effects reporting, needed to increase report submissions and data quality through a more engaging, mobile-first solution. Their challenge was to build a conversational bot that provided an intuitive user experience while adhering to strict regulatory requirements. They partnered with OpenDialog to develop this solution using its conversational AI platform.

Using OpenDialog's conversation builder and custom webchat, MyMeds&Me created an adaptive conversational application that guides users through the complex reporting process. The solution integrated seamlessly with MyMeds&Me's existing product suite, pulling in up-to-date drug data to ensure quality. OpenDialog provided a platform that allowed for quick patient navigation, collected key data points reliably, and future-proofed MyMeds&Me's capabilities for long-term development.

MyMeds&Me

John Fitzpatrick

MyMeds&Me